Please login to the form below

Not currently logged in
Email:
Password:

endometrial cancer

This page shows the latest endometrial cancer news and features for those working in and with pharma, biotech and healthcare.

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

Merck &Co – known as MSD outside the US and Canada – has announced that Keytruda (pembrolizumab) has been approved by the US Food and Drug Administration (FDA) for advanced endometrial cancer. ... Endometrial cancer is the most common type of uterine

Latest news

More from news
Approximately 3 fully matching, plus 17 partially matching documents found.

Latest from PMHub

  • The power of influence in transforming women’s health The power of influence in transforming women’s health

    HRT continued to grow in popularity after the 1960s, particularly with research showing the links between certain doses and a reduced risk of endometrial cancer. ... iv] Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....